FI871539A0 - Foerfarande foer framstaellning av fasta farmaceutiska preparat. - Google Patents

Foerfarande foer framstaellning av fasta farmaceutiska preparat.

Info

Publication number
FI871539A0
FI871539A0 FI871539A FI871539A FI871539A0 FI 871539 A0 FI871539 A0 FI 871539A0 FI 871539 A FI871539 A FI 871539A FI 871539 A FI871539 A FI 871539A FI 871539 A0 FI871539 A0 FI 871539A0
Authority
FI
Finland
Prior art keywords
pharmaceutiska
preparat
fasta
foerfarande foer
foer framstaellning
Prior art date
Application number
FI871539A
Other languages
English (en)
Other versions
FI87887C (fi
FI871539A (fi
FI87887B (fi
Inventor
Hans-Helmut Goertz
Roger Guenther Klimesch
Klaus Laemmerhirt
Siegfried Lang
Axel Sanner
Reinhard Spengler
Original Assignee
Basf Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Basf Ag filed Critical Basf Ag
Publication of FI871539A0 publication Critical patent/FI871539A0/fi
Publication of FI871539A publication Critical patent/FI871539A/fi
Application granted granted Critical
Publication of FI87887B publication Critical patent/FI87887B/fi
Publication of FI87887C publication Critical patent/FI87887C/fi

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2095—Tabletting processes; Dosage units made by direct compression of powders or specially processed granules, by eliminating solvents, by melt-extrusion, by injection molding, by 3D printing
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/2027—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B29—WORKING OF PLASTICS; WORKING OF SUBSTANCES IN A PLASTIC STATE IN GENERAL
    • B29K—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES B29B, B29C OR B29D, RELATING TO MOULDING MATERIALS OR TO MATERIALS FOR MOULDS, REINFORCEMENTS, FILLERS OR PREFORMED PARTS, e.g. INSERTS
    • B29K2105/00—Condition, form or state of moulded material or of the material to be shaped
    • B29K2105/0005—Condition, form or state of moulded material or of the material to be shaped containing compounding ingredients
    • B29K2105/0035—Medical or pharmaceutical agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Surgical Instruments (AREA)
  • Measuring Pulse, Heart Rate, Blood Pressure Or Blood Flow (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Steroid Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Cephalosporin Compounds (AREA)
FI871539A 1986-04-11 1987-04-08 Foerfarande foer framstaellning av fasta farmaceutiska preparat FI87887C (fi)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19863612212 DE3612212A1 (de) 1986-04-11 1986-04-11 Verfahren zur herstellung von festen pharmazeutischen formen
DE3612212 1986-04-11

Publications (4)

Publication Number Publication Date
FI871539A0 true FI871539A0 (fi) 1987-04-08
FI871539A FI871539A (fi) 1987-10-12
FI87887B FI87887B (fi) 1992-11-30
FI87887C FI87887C (fi) 1993-03-10

Family

ID=6298473

Family Applications (1)

Application Number Title Priority Date Filing Date
FI871539A FI87887C (fi) 1986-04-11 1987-04-08 Foerfarande foer framstaellning av fasta farmaceutiska preparat

Country Status (20)

Country Link
US (1) US4801460A (fi)
EP (1) EP0240904B1 (fi)
JP (1) JPH089551B2 (fi)
KR (1) KR920003575B1 (fi)
CN (1) CN1022666C (fi)
AT (1) ATE77739T1 (fi)
AU (1) AU587897B2 (fi)
CA (1) CA1308353C (fi)
CS (1) CS268177B2 (fi)
DE (2) DE3612212A1 (fi)
ES (1) ES2037020T3 (fi)
FI (1) FI87887C (fi)
GR (1) GR3005866T3 (fi)
HU (1) HU196132B (fi)
MD (1) MD374C2 (fi)
NO (1) NO170570C (fi)
PT (1) PT84661B (fi)
SU (1) SU1731037A3 (fi)
UA (1) UA13038A1 (fi)
YU (1) YU46534B (fi)

Families Citing this family (153)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3612211A1 (de) * 1986-04-11 1987-10-15 Basf Ag Kontinuierliches verfahren zum tablettieren
US5051261A (en) * 1987-11-24 1991-09-24 Fmc Corporation Method for preparing a solid sustained release form of a functionally active composition
CA1334379C (en) * 1987-11-24 1995-02-14 James William Mcginity Method for preparing a solid sustained release form of a functionally active composition
DE3803482A1 (de) * 1988-02-05 1989-08-17 Lohmann Therapie Syst Lts Schwimmfaehiges orales therapeutisches system
DE3807895A1 (de) * 1988-03-10 1989-09-21 Knoll Ag Erzeugnisse, enthaltend einen calciumantagonisten und einen lipidsenker
DE3812567A1 (de) * 1988-04-15 1989-10-26 Basf Ag Verfahren zur herstellung pharmazeutischer mischungen
DE3830353A1 (de) * 1988-09-07 1990-03-15 Basf Ag Verfahren zur kontinuierlichen herstellung von festen pharmazeutischen formen
DE3830355A1 (de) * 1988-09-07 1990-03-15 Basf Ag Verfahren zur herstellung von pharmazeutischen tabletten
PH26730A (en) * 1988-12-30 1992-09-28 Ciba Geigy Ag Coated adhesive tablets
US5310549A (en) * 1989-08-31 1994-05-10 Ecolab Inc. Solid concentrate iodine composition
WO1991007184A1 (en) * 1989-11-08 1991-05-30 Gaf Chemicals Corporation SUBSTANTIALLY ANHYDROUS COMPLEXES OF PVP and H2O¿2?
US5008106A (en) * 1989-12-14 1991-04-16 Gaf Chemicals Corporation Method for reducing the microbial content of surfaces with a microbiocidal, anhydrous complex of PVP-H2 O2
IE63986B1 (en) * 1989-12-30 1995-06-28 Akzo Nv Pharmaceutical preparation for oral administration in fluid form
FR2663818B1 (fr) † 1990-06-29 1993-07-09 Rhone Poulenc Nutrition Animale Procede de preparation de granules de principes actifs par extrusion.
DE4031881C2 (de) * 1990-10-08 1994-02-24 Sanol Arznei Schwarz Gmbh Lösungsmittelfreie, oral zu verabreichende pharmazeutische Zubereitung mit verzögerter Wirkstoffreisetzung und Verfahren zu deren Herstellung
CA2065603C (en) * 1991-04-09 2007-04-03 Hiroki Itoh Stabilized vitamin d preparation
DK0580860T4 (da) * 1991-04-16 2005-03-21 Nippon Shinyaku Co Ltd Fremgangsmåde til fremstilling af en fast dispersion
US5286497A (en) * 1991-05-20 1994-02-15 Carderm Capital L.P. Diltiazem formulation
US5326570A (en) * 1991-07-23 1994-07-05 Pharmavene, Inc. Advanced drug delivery system and method of treating psychiatric, neurological and other disorders with carbamazepine
AU651247B2 (en) 1991-09-06 1994-07-14 Mcneilab, Inc. Composition comprising a tramadol material and acetaminophen and its use
WO1993007859A1 (en) * 1991-10-23 1993-04-29 Warner-Lambert Company Novel pharmaceutical pellets and process for their production
DE4138513A1 (de) * 1991-11-23 1993-05-27 Basf Ag Feste pharmazeutische retardform
AU671811B2 (en) 1991-12-18 1996-09-12 Warner-Lambert Company A process for the preparation of a solid dispersion
US5190749A (en) * 1992-01-13 1993-03-02 Isp Investments Inc. Copolymers of vinyl pyrrolidone and a quaternary ammonium monomer complexed with H2 O2 in the form of free-flowing powders
US5429825A (en) * 1992-06-26 1995-07-04 Mcneil-Ppc, Inc. Rotomelt granulation
TW246635B (fi) * 1992-10-08 1995-05-01 Shell Internat Res Schappej B V
NZ260408A (en) * 1993-05-10 1996-05-28 Euro Celtique Sa Controlled release preparation comprising tramadol
DE4316537A1 (de) * 1993-05-18 1994-11-24 Basf Ag Zubereitungen in Form fester Lösungen
DE69432186T2 (de) * 1993-11-18 2004-05-06 Nippon Shinyaku Co., Ltd. Verfahren zur herstellung stabiler arzneimittel
US5891471A (en) * 1993-11-23 1999-04-06 Euro-Celtique, S.A. Pharmaceutical multiparticulates
KR100354702B1 (ko) * 1993-11-23 2002-12-28 유로-셀티크 소시에떼 아노뉨 약학조성물의제조방법및서방형조성물
US5843480A (en) * 1994-03-14 1998-12-01 Euro-Celtique, S.A. Controlled release diamorphine formulation
DE4413350A1 (de) 1994-04-18 1995-10-19 Basf Ag Retard-Matrixpellets und Verfahren zu ihrer Herstellung
EP0691124A1 (en) * 1994-07-07 1996-01-10 Sara Lee/DE N.V. Mouth care products
GB9422154D0 (en) * 1994-11-03 1994-12-21 Euro Celtique Sa Pharmaceutical compositions and method of producing the same
US5965161A (en) 1994-11-04 1999-10-12 Euro-Celtique, S.A. Extruded multi-particulates
US20020006438A1 (en) * 1998-09-25 2002-01-17 Benjamin Oshlack Sustained release hydromorphone formulations exhibiting bimodal characteristics
US5871776A (en) * 1995-01-31 1999-02-16 Mehta; Atul M. Controlled-release nifedipine
DE19504832A1 (de) * 1995-02-14 1996-08-22 Basf Ag Feste Wirkstoff-Zubereitungen
DE19509805A1 (de) * 1995-03-21 1996-09-26 Basf Ag Transparente, schnell freisetzende Zubereitungen von nichtsteroidalen Analgetica
DE19509806A1 (de) * 1995-03-21 1996-09-26 Basf Ag Lagerstabile Arzneiformen
DE19511131A1 (de) * 1995-03-27 1996-10-02 Basf Ag Mechanisch stabile feste Wirkstoffzubereitungsformen
US5900425A (en) * 1995-05-02 1999-05-04 Bayer Aktiengesellschaft Pharmaceutical preparations having controlled release of active compound and processes for their preparation
BE1009375A6 (nl) * 1995-05-29 1997-02-04 Picanol Nv Kanteninrichting voor weefmachines.
US20060280774A1 (en) * 1995-06-02 2006-12-14 Allergan, Inc. Compositions and methods for treating glaucoma
US5869079A (en) * 1995-06-02 1999-02-09 Oculex Pharmaceuticals, Inc. Formulation for controlled release of drugs by combining hydrophilic and hydrophobic agents
JPH11514979A (ja) * 1995-09-07 1999-12-21 フイズ テクノロジーズ リミテッド 実質的に非溶解性の生体作用薬剤をバイオ・アベイラブルにするシステム
DE19539361A1 (de) * 1995-10-23 1997-04-24 Basf Ag Verfahren zur Herstellung von mehrschichtigen, festen Arzneiformen zur oralen oder rektalen Verabreichung
DE19602206A1 (de) * 1996-01-23 1997-07-24 Basf Ag Zubereitungen nichtsteroidaler Analgetika
US6090419A (en) * 1996-05-02 2000-07-18 Mccormick & Company, Inc. Salt compositions and method of preparation
DE19629040A1 (de) * 1996-07-19 1998-01-22 Basf Ag Pflanzenextrakthaltige Arzneiformen
DE19629753A1 (de) 1996-07-23 1998-01-29 Basf Ag Verfahren zur Herstellung von festen Arzneiformen
DE19635676A1 (de) * 1996-09-03 1998-03-05 Basf Ag Feste geschäumte Wirkstoffzubereitungen
TW474824B (en) 1996-09-13 2002-02-01 Basf Ag The production of solid pharmaceutical forms
DE19710213A1 (de) * 1997-03-12 1998-09-17 Basf Ag Verfahren zur Herstellung von festen Kombinationsarzneiformen
DE19753298A1 (de) * 1997-12-01 1999-06-02 Basf Ag Verfahren zur Herstellung von festen Dosierungsformen
DE19812688A1 (de) * 1998-03-23 1999-09-30 Basf Ag Verfahren zur Herstellung von festen Dosierungsformen
DE19814730A1 (de) * 1998-04-02 1999-10-07 Basf Ag Verwendung von N-Vinyllacram oder N-Vinylamin haltigen Copolymeren als Matrix zur Herstellung von festen pharmazeutischen und kosmetischen Darreichungsformen
DK1083790T3 (da) 1998-04-30 2004-06-01 Basf Ag Retardformuleringer af aktive stoffer til plantebeskyttelse
US6197347B1 (en) 1998-06-29 2001-03-06 Andrx Pharmaceuticals, Inc. Oral dosage for the controlled release of analgesic
DE19840256A1 (de) 1998-09-03 2000-03-09 Basf Ag Verfahren zur Herstellung von beschichteten festen Dosierungsformen
DE19841244A1 (de) 1998-09-09 2000-03-16 Knoll Ag Verfahren und Vorrichtung zum Herstellen von Tabletten
DE19842914A1 (de) 1998-09-18 2000-03-23 Basf Ag Testsystem zur Charakterisierung der Verträglichkeit von biologisch aktiven Substanzen und Polyvinylpyrrolidon
DE19842753A1 (de) 1998-09-18 2000-03-23 Bayer Ag Agitationsunabhängige pharmazeutische Retardzubereitungen und Verfahren zu ihrer Herstellung
DE19843904A1 (de) 1998-09-24 2000-03-30 Basf Ag Feste Dosierungsform mit polymerem Bindemittel
DE19843903A1 (de) * 1998-09-24 2000-03-30 Basf Ag Feste Dosierungsform mit copolymerem Bindemittel
DE19847618A1 (de) 1998-10-15 2000-04-20 Basf Ag Verfahren zur Herstellung von festen Dosierungsformen
WO2000028816A1 (de) * 1998-11-12 2000-05-25 Basf Aktiengesellschaft Pflanzenschutzmitteltabletten
DE19853985A1 (de) * 1998-11-23 2000-05-25 Basf Ag Verfahren zur Herstellung von festen Dosierungsformen
US6455526B1 (en) 1998-12-16 2002-09-24 Aventis Pharmaceuticals, Inc. Biodegradable polymer encapsulated pharmaceutical compositions and method for preparing the same
CN1195497C (zh) * 1998-12-16 2005-04-06 阿温蒂斯药物公司 生物可降解聚合物包封的5－羟色胺受体拮抗剂及其制备方法
DE19901383A1 (de) 1999-01-15 2000-07-20 Knoll Ag Verfahren zur Herstellung unterschiedlicher fester Dosierungsformen
DE19913692A1 (de) 1999-03-25 2000-09-28 Basf Ag Mechanisch stabile pharmazeutische Darreichungsformen, enthaltend flüssige oder halbfeste oberflächenaktive Substanzen
DE19918325A1 (de) 1999-04-22 2000-10-26 Euro Celtique Sa Verfahren zur Herstellung von Arzneiformen mit regulierter Wirkstofffreisetzung mittels Extrusion
DE19934610A1 (de) * 1999-07-23 2001-01-25 Bayer Ag Schnellfreisetzende Extrudate und Verfahren zu ihrer Herstellung sowie daraus erhältliche Zubereitungen
DE19943501A1 (de) * 1999-09-10 2001-03-15 Basf Ag Unterwassergranulation wirkstoffhaltiger Schmelzen
DE19945982A1 (de) 1999-09-24 2001-03-29 Knoll Ag Geschwindigkeitsbestimmte Partikel
US6331313B1 (en) 1999-10-22 2001-12-18 Oculex Pharmaceticals, Inc. Controlled-release biocompatible ocular drug delivery implant devices and methods
US7364752B1 (en) 1999-11-12 2008-04-29 Abbott Laboratories Solid dispersion pharamaceutical formulations
EP1175205B1 (en) * 1999-11-12 2006-06-14 Abbott Laboratories Solid dispersion comprising ritonavir, fenofibrate or griseofulvin
US6544553B1 (en) * 1999-12-28 2003-04-08 Watson Pharmaceuticals, Inc. Dosage forms and methods for oral delivery of progesterone
DE10017102A1 (de) 2000-04-06 2001-10-11 Basf Ag Verfahren zur Herstellung von festen Kreatin-Dosierungsformen und dadurch erhältliche Dosierungsformen
US6635277B2 (en) 2000-04-12 2003-10-21 Wockhardt Limited Composition for pulsatile delivery of diltiazem and process of manufacture
DE10026698A1 (de) * 2000-05-30 2001-12-06 Basf Ag Selbstemulgierende Wirkstoffformulierung und Verwendung dieser Formulierung
DE10029201A1 (de) * 2000-06-19 2001-12-20 Basf Ag Verfahren zur Herstellung fester oraler Darreichungsformen mit retardierender Wirkstoffreisetzung
US6726918B1 (en) 2000-07-05 2004-04-27 Oculex Pharmaceuticals, Inc. Methods for treating inflammation-mediated conditions of the eye
US6500457B1 (en) 2000-08-14 2002-12-31 Peirce Management, Llc Oral pharmaceutical dosage forms for pulsatile delivery of an antiarrhythmic agent
DE10046541A1 (de) * 2000-09-19 2002-03-28 Knoll Ag Mechanisch stabile darreichungsformen, enthaltend Ubichinone
US6699493B2 (en) 2000-11-29 2004-03-02 Oculex Pharmaceuticals, Inc. Method for reducing or preventing transplant rejection in the eye and intraocular implants for use therefor
US20050175687A1 (en) * 2001-01-30 2005-08-11 Mcallister Stephen M. Pharmaceutical formulations
US7883721B2 (en) 2001-01-30 2011-02-08 Smithkline Beecham Limited Pharmaceutical formulation
GB0102342D0 (en) 2001-01-30 2001-03-14 Smithkline Beecham Plc Pharmaceutical formulation
US7842308B2 (en) * 2001-01-30 2010-11-30 Smithkline Beecham Limited Pharmaceutical formulation
GB0113841D0 (en) * 2001-06-07 2001-08-01 Boots Co Plc Therapeutic agents
US20050202090A1 (en) * 2002-01-03 2005-09-15 Clarke Allan J. Novel pharmaceutical dosage forms and method for producing same
KR20040083493A (ko) 2002-02-01 2004-10-02 화이자 프로덕츠 인크. 콜레스테릴 에스테르 전달 단백질 억제제의 제어 방출형제약상 제형
AR038375A1 (es) 2002-02-01 2005-01-12 Pfizer Prod Inc Composiciones farmaceuticas de inhibidores de la proteina de transferencia de esteres de colesterilo
US20050182056A9 (en) * 2002-02-21 2005-08-18 Seth Pawan Modified release formulations of at least one form of tramadol
US8128957B1 (en) 2002-02-21 2012-03-06 Valeant International (Barbados) Srl Modified release compositions of at least one form of tramadol
MXPA04008903A (es) * 2002-03-11 2004-11-26 Alcon Inc Sistema de suministro de farmaco implantable.
DE10213242A1 (de) * 2002-03-25 2003-10-16 Abbott Gmbh & Co Kg Testsystem zur Evaluierung der Kompatibilität biologisch aktiver Substanzen mit Copolymeren
ES2333318T3 (es) 2002-08-12 2010-02-19 Bend Research, Inc. Composiciones farmaceuticas de medicamentos con estructura semiordenada y de polimero.
EP1545468A4 (en) * 2002-09-20 2007-06-20 Alpharma Inc SUSTAINED RELEASE OPIOID PREPARATIONS AND METHODS OF USE
DE10247037A1 (de) * 2002-10-09 2004-04-22 Abbott Gmbh & Co. Kg Herstellung von festen Dosierungsformen unter Verwendung eines vernetzten nichtthermoplastischen Trägers
JP2006511541A (ja) * 2002-12-17 2006-04-06 アボット ゲーエムベーハー ウント カンパニー カーゲー フェノフィブル酸、その生理学的に許容し得る塩または誘導体を含有してなる製剤
US20080051411A1 (en) * 2002-12-17 2008-02-28 Cink Russell D Salts of Fenofibric Acid and Pharmaceutical Formulations Thereof
US20050048099A1 (en) 2003-01-09 2005-03-03 Allergan, Inc. Ocular implant made by a double extrusion process
WO2004069180A2 (en) * 2003-01-31 2004-08-19 Smithkline Beecham Corporation Solid dispersion compositions
CA2509958A1 (en) * 2003-02-03 2004-08-19 Novartis Ag Pharmaceutical formulation
US20050100608A1 (en) * 2003-02-21 2005-05-12 Watson Pharmaceuticals, Inc. Testosterone oral dosage formulations and associated methods
US20040219210A1 (en) * 2003-05-01 2004-11-04 Jian-Hwa Guo Controlled release solid dosage nifedipine formulations
US7250475B2 (en) * 2003-06-26 2007-07-31 Symyx Technologies, Inc. Synthesis of photoresist polymers
TW200526274A (en) 2003-07-21 2005-08-16 Smithkline Beecham Plc Pharmaceutical formulations
US8377952B2 (en) 2003-08-28 2013-02-19 Abbott Laboratories Solid pharmaceutical dosage formulation
US8025899B2 (en) 2003-08-28 2011-09-27 Abbott Laboratories Solid pharmaceutical dosage form
WO2005027864A1 (en) * 2003-09-19 2005-03-31 Symyx Technologies, Inc. Materials for enhanced delivery of hydrophilic active agents in personal care formulations
KR20060125805A (ko) * 2003-11-18 2006-12-06 베링거 인겔하임 인터내셔날 게엠베하 고체 약제학적 제제 형태
GB0403098D0 (en) * 2004-02-12 2004-03-17 Euro Celtique Sa Extrusion
TWI350762B (en) * 2004-02-12 2011-10-21 Euro Celtique Sa Particulates
PE20060003A1 (es) * 2004-03-12 2006-03-01 Smithkline Beecham Plc Formulacion farmaceutica polimerica para moldear por inyeccion
US20050244469A1 (en) * 2004-04-30 2005-11-03 Allergan, Inc. Extended therapeutic effect ocular implant treatments
EP1750669A1 (en) * 2004-05-04 2007-02-14 Boehringer Ingelheim International Gmbh Solid pharmaceutical form comprising an ltb4 antagonist
EP1748762B1 (de) 2004-05-28 2013-12-18 AbbVie Deutschland GmbH & Co KG Dosierungsform, erhältlich aus einer ein anorganisches pigment umfassenden pulvermischung
FR2875409B1 (fr) * 2004-09-17 2010-05-07 Sanofi Aventis Composition pharmaceutique comprenant une dispersion solide a matrice polymere comprenant une phase continue de polydextrose et une phase continue d'un polymere autre que du polydextrose
WO2006122022A2 (en) * 2005-05-10 2006-11-16 Novartis Ag Modified release famciclovir pharmaceutical compositions
WO2007002597A2 (en) 2005-06-27 2007-01-04 Biovail Laboratories International S.R.L. Modified-release formulations of a bupropion salt
DE602006016127D1 (de) * 2005-07-05 2010-09-23 Abbott Gmbh & Co Kg Zusammensetzung und dosierform mit einer festen oder halbfesten matrix
JP2009504590A (ja) 2005-08-08 2009-02-05 アボット ゲーエムベーハー ウント コンパニー カーゲー 改善された生物学的利用能をもつ剤型
US8486456B2 (en) 2005-08-08 2013-07-16 Abbott Gmbh & Co., Kg Itraconazole compositions with improved bioavailability
US7534381B2 (en) * 2005-09-14 2009-05-19 Isp Investments Inc. Process and apparatus for forming agglomerates of a powder composition of an active and binder
US20070178138A1 (en) * 2006-02-01 2007-08-02 Allergan, Inc. Biodegradable non-opthalmic implants and related methods
EP1832281A1 (en) * 2006-03-10 2007-09-12 Abbott GmbH & Co. KG Process for producing a solid dispersion of an active ingredient
US8802128B2 (en) * 2006-06-23 2014-08-12 Allergan, Inc. Steroid-containing sustained release intraocular implants and related methods
US20070298073A1 (en) * 2006-06-23 2007-12-27 Allergan, Inc. Steroid-containing sustained release intraocular implants and related methods
US20080057122A1 (en) * 2006-08-31 2008-03-06 Aaipharma Inc. Acetaminophen pharmaceutical compositions
CA2669938C (en) * 2006-11-15 2016-01-05 Abbott Laboratories Solid pharmaceutical dosage formulations
US20080145405A1 (en) * 2006-12-15 2008-06-19 Kunzler Jay F Drug delivery devices
US7607596B1 (en) 2007-03-07 2009-10-27 Exxpharma, LLC Process for enhancing the solubility of poorly soluble drugs
JP2011503048A (ja) 2007-11-08 2011-01-27 グラクソ グループ リミテッド 医薬製剤
US20090246276A1 (en) 2008-01-28 2009-10-01 Graham Jackson Pharmaceutical Compositions
WO2009150228A2 (en) * 2008-06-13 2009-12-17 Glaxo Group Limited Pharmaceutical formulations
US20100003322A1 (en) * 2008-07-03 2010-01-07 Lai Felix S Enteric coated hydrophobic matrix formulation
EP2346495B2 (en) * 2008-10-07 2023-05-24 Kudos Pharmaceuticals Limited Pharmaceutical formulation 514
EP2349218B1 (de) * 2008-10-07 2013-09-18 Basf Se Verfahren zur herstellung oraler darreichungsformen mit kontrollierter freisetzung
EP2477593A1 (de) * 2009-09-18 2012-07-25 Basf Se Verfahren zur herstellung von zubereitungen von in wasser schwer löslichen substanzen
EP2536393B1 (en) 2010-02-18 2014-04-16 AbbVie Deutschland GmbH & Co KG Test solvent for evaluating the compatibility of biologically active substances and graft copolymers
EP2463327A3 (de) 2010-12-10 2015-06-03 Basf Se Verfahren zur herstellung von granulaten, enthaltend mindestens eine wasserlösliche komponente
SG191316A1 (en) 2010-12-23 2013-07-31 Abbott Gmbh & Co Kg Solid retard formulations based on solid dispersions
KR102448369B1 (ko) 2014-02-05 2022-09-28 머크 샤프 앤드 돔 엘엘씨 Cgrp-활성 화합물에 대한 정제 제제
CN104666084B (zh) * 2014-11-27 2018-07-13 天津坤健生物制药有限公司 一种提高缓控释包衣片溶出度稳定性的方法
MD4399C1 (ro) * 2015-02-19 2016-09-30 Государственный Университет Молд0 Material polimeric cu proprietăţi antibacteriene
BR112019005774B1 (pt) 2016-09-27 2022-10-11 L.P. Brown Company, Inc Folhas de material de embalagem de fardos colhidos
AU2018360383A1 (en) 2017-11-02 2020-05-21 Natureceuticals Sdn. Bhd. Extract of orthosiphon stamineus, formulations, and uses thereof

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3089818A (en) * 1960-06-02 1963-05-14 Baxter Laboratories Inc Water dispersible antibiotics
DE1137009B (de) * 1961-01-04 1962-09-27 Bayer Ag Verfahren zur Herstellung eines leichtloeslichen Streptomycinsalzes
NL297357A (fi) * 1962-08-31
GB1348786A (en) * 1971-05-14 1974-03-20 Plessey Co Ltd Apparatus and methods for assessing the length of a moving vehicle
GB1388786A (en) * 1972-04-03 1975-03-26 Scherer Corp R P Integral solid gel-lattice dosage form of high-moisture content
CA1211892A (en) * 1982-09-20 1986-09-23 James R. Cho Preparation of polyvinylpyrrolidone or vinylpyrrolidone/vinyl acetate copolymers of various molecular weights using a single initiator system
FI82188C (fi) * 1983-03-16 1991-02-11 Boehringer Ingelheim Ltd Foerfarande foer framstaellning av en vattenloeslig, farmaceutiskt godtagbar dispersion av klortalidon.
DE3312668A1 (de) * 1983-04-08 1984-10-11 Basf Ag, 6700 Ludwigshafen Wasserloesliche polymere mit geringer hygroskopie
US4661521A (en) * 1984-04-30 1987-04-28 Mallinckrodt, Inc. Direct tableting acetaminophen compositions
US4631284A (en) * 1984-11-19 1986-12-23 Mallinckrodt, Inc. Acetaminophen compositions containing low doses of chlorpheniramine maleate, method for preparing same and tablets formed therefrom
FR2581541B1 (fr) * 1985-05-09 1988-05-20 Rhone Poulenc Sante Nouvelles compositions pharmaceutiques permettant la liberation prolongee d'un principe actif et leur procede de preparation
EP0214092A1 (en) * 1985-08-08 1987-03-11 Ciba-Geigy Ag Enhanced absorption of psychoactive 2-aryl-pyrazolo quinolines as a solid molecular dispersion in polyvinylpyrrolidone

Also Published As

Publication number Publication date
CS253287A2 (en) 1989-04-14
EP0240904A3 (en) 1988-11-30
NO170570C (no) 1992-11-04
US4801460A (en) 1989-01-31
NO871513L (no) 1987-10-12
HU196132B (en) 1988-10-28
SU1731037A3 (ru) 1992-04-30
AU587897B2 (en) 1989-08-31
PT84661B (pt) 1989-11-30
EP0240904A2 (de) 1987-10-14
DE3780059D1 (de) 1992-08-06
CS268177B2 (en) 1990-03-14
KR870009715A (ko) 1987-11-30
GR3005866T3 (fi) 1993-06-07
CN1022666C (zh) 1993-11-10
YU46534B (sh) 1993-11-16
UA13038A1 (uk) 1997-02-28
PT84661A (en) 1987-05-01
MD374C2 (ro) 1996-05-31
AU7141387A (en) 1987-10-15
JPS62242630A (ja) 1987-10-23
CA1308353C (en) 1992-10-06
EP0240904B1 (de) 1992-07-01
CN87103409A (zh) 1987-12-09
YU59187A (en) 1988-08-31
FI87887C (fi) 1993-03-10
ES2037020T3 (es) 1993-06-16
FI871539A (fi) 1987-10-12
DE3612212A1 (de) 1987-10-15
ATE77739T1 (de) 1992-07-15
FI87887B (fi) 1992-11-30
NO170570B (no) 1992-07-27
HUT43958A (en) 1988-01-28
JPH089551B2 (ja) 1996-01-31
KR920003575B1 (ko) 1992-05-04
NO871513D0 (no) 1987-04-10

Similar Documents

Publication Publication Date Title
FI871539A (fi) Foerfarande foer framstaellning av fasta farmaceutiska preparat.
IT8119321A0 (it) Procedimento per ottenere eparine di basso peso molecolare dotate di proprieta' farmacologiche elevate, e prodotto cosi' ottenuto.
DK0544144T3 (da) Fast farmaceutisk retardform
ATE103914T1 (de) Neue thienylcarbonsaeureester von aminoalkoholen, ihre quaternierungsprodukte sowie die herstellung und verwendung dieser verbindungen.
ATE45283T1 (de) Zusammensetzungen fuer die herstellung von mikropartikeln durch extrusion fuer verzoegerte abgabe von biologisch aktiven substanzen und so erhaltene mikropartikel.
OA05630A (fr) Nouveaux dérivés phénoxybenzyloxycarbonyliques substitués, leur procédé de préparation et leur application comme insecticides et acaricides.
SE8204581D0 (sv) New pharmaceutical sustained-release compositions
NO880754L (no) Polymerer og fremgangsmaate for deres fremstilling.
JPS5363310A (en) Preparation of monomer composition containing pb and preparation of polymerhaving radiation shielding ability
JPS55115417A (en) Manufacture of propylene copolymer
IT8821877A0 (it) Componente di catalizzatore per laproduzione di poliolefine ad altissimo peso molecolare.
FR2281933A1 (fr) Nouveaux composes stilbeniques, leur procede de preparation et leur utilisation comme azurants optiques de matieres organiques a haut poids moleculaire
IL96441A0 (en) Polymers with alkyl-or heteroalkyl-aryl backbone,processes for the preparation thereof and pharmaceutical compositions containing the same
BE861876A (fr) Nouvelles formulations d'antibiotiques beta-lactame leur procede de preparation, melange antibiotique injectable ainsi que son procede de preparation
BE854619A (fr) Nouveaux phosphites organiques, leur preparation et leur utilisation comme stabilisants pour des matieres macromoleculaires
FR2456118B1 (fr) Procede de preparation de polymeres insatures reticules, ces polymeres eux-memes et leur application a la fabrication d'objets moules
ATE61626T1 (de) Thermoplastische formmassen.
JPS523677A (en) Process for polymerization of alpha-olefins
JPS544994A (en) Epoxy resin composition
FR2366263A1 (fr) Diisocyanates aliphatiques, leur preparation et leur utilisation pour la fabrication de resines de polyurethannes
JPS5686939A (en) Production of molded product
JPS5231027A (en) Process for preparation of amphoteric compounds
JPS53137293A (en) Molding articles of insoluble aromatic polymonovinyl compound having acrylamidemethyl group, and their preparation
DK619888A (da) Fremgangsmaade til fremstilling af produkter af lignincellulosemateriale
JPS5646814A (en) Accelerator of antitumorigenic effect

Legal Events

Date Code Title Description
MM Patent lapsed

Owner name: BASF AKTIENGESELLSCHAFT